The expression levels of the estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER-2), and Ki-67 biomarker have been proven to be associated with the prognoses of breast cancer [10, 11]. This evidence concerns the gene ERBB2 and breast carcinoma.